相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Current progress and future perspectives of polypharmacology : From the view of non-small cell lung cancer
Ramanathan Karuppasamy et al.
SEMINARS IN CANCER BIOLOGY (2021)
Deep Learning Enhancing Kinome-Wide Polypharmacology Profiling: Model Construction and Experiment Validation
Xutong Li et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Epigenetic polypharmacology: A new frontier for epi-drug discovery
Daniela Tomaselli et al.
MEDICINAL RESEARCH REVIEWS (2020)
From machine learning to deep learning: Advances in scoring functions for protein-ligand docking
Chao Shen et al.
WILEY INTERDISCIPLINARY REVIEWS-COMPUTATIONAL MOLECULAR SCIENCE (2020)
Phase Ia Study of Anti-NaPi2b Antibody-Drug Conjugate Lifastuzumab Vedotin DNIB0600A in Patients with Non-Small Cell Lung Cancer and Platinum-Resistant Ovarian Cancer
David E. Gerber et al.
CLINICAL CANCER RESEARCH (2020)
Phase I study of the anti-endothelin B receptor antibody-drug conjugate DEDN6526A in patients with metastatic or unresectable cutaneous, mucosal, or uveal melanoma
Shahneen Sandhu et al.
INVESTIGATIONAL NEW DRUGS (2020)
Novel tacrine-benzofuran hybrids as potential multi-target drug candidates for the treatment of Alzheimer's Disease
Gaia Fancellu et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2020)
Therapeutic target database 2020: enriched resource for facilitating research and early development of targeted therapeutics
Yunxia Wang et al.
NUCLEIC ACIDS RESEARCH (2020)
Expression Atlas update: from tissues to single cells
Irene Papatheodorou et al.
NUCLEIC ACIDS RESEARCH (2020)
A phase 1 study of the antibody-drug conjugate brentuximab vedotin with re-induction chemotherapy in patients with CD30-expressing relapsed/refractory acute myeloid leukemia
Rupa Narayan et al.
CANCER (2020)
Proteolysis-Targeting Chimeras as Therapeutics and Tools for Biological Discovery
George M. Burslem et al.
CELL (2020)
First-in-Human Phase I Study of ABBV-838, an Antibody-Drug Conjugate Targeting SLAMF7/CS1 in Patients with Relapsed and Refractory Multiple Myeloma
Ravi Vij et al.
CLINICAL CANCER RESEARCH (2020)
Multi-target dopamine D3 receptor modulators: Actionable knowledge for drug design from molecular dynamics and machine learning
Mariarosaria Ferraro et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Identification of Target Associations for Polypharmacology from Analysis of Crystallographic Ligands of the Protein Data Bank
Luca Pinzi et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2020)
Improved protein structure prediction using potentials from deep learning
Andrew W. Senior et al.
NATURE (2020)
Coronavirus puts drug repurposing on the fast track
Charlotte Harrison
NATURE BIOTECHNOLOGY (2020)
Repurposing human kinase inhibitors to create an antibiotic active against drug-resistant Staphylococcus aureus, persisters and biofilms
Philipp Le et al.
NATURE CHEMISTRY (2020)
Engineering strategies to overcome the current roadblocks in CAR T cell therapy
Sarwish Rafiq et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Multicenter Initial Guidance on Use of Antivirals for Children With Coronavirus Disease 2019/Severe Acute Respiratory Syndrome Coronavirus 2
Kathleen Chiotos et al.
JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY (2020)
Exploring Targeted Degradation Strategy for Oncogenic KRASG12C
Mei Zeng et al.
CELL CHEMICAL BIOLOGY (2020)
Binding site matching in rational drug design: algorithms and applications
Misagh Naderi et al.
BRIEFINGS IN BIOINFORMATICS (2019)
Polypharmacology by Design: A Medicinal Chemist's Perspective on Multitargeting Compounds
Ewgenij Proschak et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Therapeutic gene editing in haematological disorders with CRISPR/Cas9
Trine I. Jensen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
First-in-human study to assess safety, tolerability, pharmacokinetics, and pharmacodynamics of the anti-CD27L antibody-drug conjugate AMG 172 in patients with relapsed/refractory renal cell carcinoma
Christophe Massard et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2019)
MolTarPred: A web tool for comprehensive target prediction with reliability estimation
Antonio Peon et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2019)
Systematic computational identification of promiscuity cliff pathways formed by inhibitors of the human kinome
Filip Miljkovic et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2019)
Harnessing Polypharmacology with Medicinal Chemistry
Maria Laura Bolognesi
ACS MEDICINAL CHEMISTRY LETTERS (2019)
Network-based prediction of drug combinations
Feixiong Cheng et al.
NATURE COMMUNICATIONS (2019)
Acquired Resistance to Antibody-Drug Conjugates
Denis M. Collins et al.
CANCERS (2019)
Design of Natural-Product-Inspired Multitarget Ligands by Machine Learning
Francesca Grisoni et al.
CHEMMEDCHEM (2019)
Histone Deacetylase Inhibitors as Multitarget Ligands: New Players in Alzheimer's Disease Drug Discovery?
Angela De Simone et al.
CHEMMEDCHEM (2019)
IBM Watson, Heal Thyself
Eliza Strickland
IEEE SPECTRUM (2019)
Rational Design of Multitarget-Directed Ligands: Strategies and Emerging Paradigms
Junting Zhou et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
The global pipeline of cell therapies for cancer
Jia Xin Yu et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Epigenetic Modulators as Potential Multi-targeted Drugs Against Hedgehog Pathway for Treatment of Cancer
Anshika N. Singh et al.
PROTEIN JOURNAL (2019)
KinomeX: a web application for predicting kinome-wide polypharmacology effect of small molecules
Zhaojun Li et al.
BIOINFORMATICS (2019)
Machine learning with the TCGA-HNSC dataset: improving usability by addressing inconsistency, sparsity, and high-dimensionality
Michael C. Rendleman et al.
BMC BIOINFORMATICS (2019)
Phenotype-Based Screens with Conformation-Specific Inhibitors Reveal p38 Gamma and Delta as Targets for HCC Polypharmacology
Jia Xin Yu et al.
MOLECULAR CANCER THERAPEUTICS (2019)
High Impact: The Role of Promiscuous Binding Sites in Polypharmacology
Natacha Cerisier et al.
MOLECULES (2019)
BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design
William Farnaby et al.
NATURE CHEMICAL BIOLOGY (2019)
Bispecific antibodies: a mechanistic review of the pipeline
Aran F. Labrijn et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Rational discovery of dual-indication multi-target PDE/Kinase inhibitor for precision anti-cancer therapy using structural systems pharmacology
Hansaim Lim et al.
PLOS COMPUTATIONAL BIOLOGY (2019)
PROTACs- a game-changing technology
Markella Konstantinidou et al.
EXPERT OPINION ON DRUG DISCOVERY (2019)
Data-Driven Construction of Antitumor Agents with Controlled Polypharmacology
Chenxiao Da et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2019)
Clinical lessons learned from the first leg of the CAR T cell journey
Robbie G. Majzner et al.
NATURE MEDICINE (2019)
A triple drug combination targeting components of the nutrient-sensing network maximizes longevity
Jorge Ivan Castillo-Quan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
First-in-Human Phase I Study of Aprutumab Ixadotin, a Fibroblast Growth Factor Receptor 2 Antibody-Drug Conjugate (BAY 1187982) in Patients with Advanced Cancer
Sung-Bae Kim et al.
TARGETED ONCOLOGY (2019)
A Phase I Study of ADCT-402 (Loncastuximab Tesirine), a Novel Pyrrolobenzodiazepine-Based Antibody-Drug Conjugate, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma
Brad S. Kahl et al.
CLINICAL CANCER RESEARCH (2019)
Phase II trial of the glycoprotein non-metastatic B-targeted antibody-drug conjugate, glembatumumab vedotin (CDX-011), in recurrent osteosarcoma AOST1521: A report from the Children's Oncology Group
Lisa M. Kopp et al.
EUROPEAN JOURNAL OF CANCER (2019)
LightGBM: An Effective and Scalable Algorithm for Prediction of Chemical Toxicity-Application to the Tox21 and Mutagenicity Data Sets
Jin Zhang et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2019)
Targeted protein degradation: expanding the toolbox
Matthieu Schapira et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Network-Based Assessment of Adverse Drug Reaction Risk in Polypharmacy Using High-Throughput Screening Data
Guillermo de Anda-Jauregui et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Hit Dexter 2.0: Machine-Learning Models for the Prediction of Frequent Hitters
Conrad Stork et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2019)
Polypharmacology Browser PPB2: Target Prediction Combining Nearest Neighbors with Machine Learning
Mahendra Awale et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2019)
Phase I Study of DSTP3086S, an Antibody-Drug Conjugate Targeting Six-Transmembrane Epithelial Antigen of Prostate 1, in Metastatic Castration-Resistant Prostate Cancer
Daniel C. Danila et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
canSAR: update to the cancer translational research and drug discovery knowledgebase
Elizabeth A. Coker et al.
NUCLEIC ACIDS RESEARCH (2019)
A selective BCL-XL PROTAC degrader achieves safe and potent antitumor activity
Sajid Khan et al.
NATURE MEDICINE (2019)
Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity
Marc Hafner et al.
CELL CHEMICAL BIOLOGY (2019)
Binding site characterization - similarity, promiscuity, and druggability
Christiane Ehrt et al.
MEDCHEMCOMM (2019)
Promiscuous Ligands from Experimentally Determined Structures, Binding Conformations, and Protein Family-Dependent Interaction Hotspots
Erik Gilberg et al.
ACS OMEGA (2019)
Improving the efficacy-safety balance of polypharmacology in multi-target drug discovery
Balaguru Ravikumar et al.
EXPERT OPINION ON DRUG DISCOVERY (2018)
Modeling polypharmacy side effects with graph convolutional networks
Marinka Zitnik et al.
BIOINFORMATICS (2018)
5-HT2C Receptor Structures Reveal the Structural Basis of GPCR Polypharmacology
Yao Peng et al.
CELL (2018)
Combination Therapy for Multi-Target Manipulation of Secondary Brain Injury Mechanisms
Mahadevabharath R. Somayaji et al.
CURRENT NEUROPHARMACOLOGY (2018)
A novel dual PPAR-γ agonist/sEH inhibitor treats diabetic complications in a rat model of type 2 diabetes
Md Abdul Hye Khan et al.
DIABETOLOGIA (2018)
Rational Approaches for Combination Therapy Strategies Targeting the MAP Kinase Pathway in Solid Tumors
Anthony W. Tolcher et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Mechanisms and clinical activity of an EGFR and HER2 exon 20-selective kinase inhibitor in non-small cell lung cancer
Jacqulyne P. Robichaux et al.
NATURE MEDICINE (2018)
Computational identification of the binding mechanism of a triple reuptake inhibitor amitifadine for the treatment of major depressive disorder
Weiwei Xue et al.
PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2018)
Effect of missing data on multitask prediction methods
Antonio de la Vega de Leon et al.
JOURNAL OF CHEMINFORMATICS (2018)
Selection of protein conformations for structure-based polypharmacology studies
Luca Pinzi et al.
DRUG DISCOVERY TODAY (2018)
Probing the chemical-biological relationship space with the Drug Target Explorer
Robert J. Allaway et al.
JOURNAL OF CHEMINFORMATICS (2018)
Machine Learning Distinguishes with High Accuracy between Pan-Assay Interference Compounds That Are Promiscuous or Represent Dark Chemical Matter
Swarit Jasial et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Enhancing Molecular Promiscuity Evaluation Through Assay Profiles
Sorin Avram et al.
PHARMACEUTICAL RESEARCH (2018)
The ReFRAME library as a comprehensive drug repurposing library and its application to the treatment of cryptosporidiosis
Jeff Janes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Privileged Structures and Polypharmacology within and between Protein Families
Joshua Meyers et al.
ACS MEDICINAL CHEMISTRY LETTERS (2018)
Network-Based Methods for Prediction of Drug-Target Interactions
Zengrui Wu et al.
FRONTIERS IN PHARMACOLOGY (2018)
Systematic polypharmacology and drug repurposing via an integrated L1000-based Connectivity Map database mining
Tsang-Pai Liu et al.
ROYAL SOCIETY OPEN SCIENCE (2018)
A perspective on multi-target drug discovery and design for complex diseases
Rona R. Ramsay et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2018)
A Chemoproteomic Approach to Query the Degradable Kinome Using a Multi-kinase Degrader
Hai-Tsang Huang et al.
CELL CHEMICAL BIOLOGY (2018)
Lessons in PROTAC Design from Selective Degradation with a Promiscuous Warhead
Daniel P. Bondeson et al.
CELL CHEMICAL BIOLOGY (2018)
A comprehensive map of molecular drug targets
Rita Santos et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
A First-in-Class Small-Molecule that Acts as a Dual Inhibitor of HDAC and PDE5 and that Rescues Hippocampal Synaptic Impairment in Alzheimer's Disease Mice
Mar Cuadrado-Tejedor et al.
NEUROPSYCHOPHARMACOLOGY (2017)
Tacrine-resveratrol fused hybrids as multi-target-directed ligands against Alzheimer's disease
Jakub Jerabek et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Computational polypharmacology: a new paradigm for drug discovery
Rajan Chaudhari et al.
EXPERT OPINION ON DRUG DISCOVERY (2017)
A comprehensive review of uncommon EGFR mutations in patients with non-small cell lung cancer
Hai-Yan Tu et al.
LUNG CANCER (2017)
Synergistic target combination prediction from curated signaling networks: Machine learning meets systems biology and pharmacology
Huey Eng Chua et al.
METHODS (2017)
Mastering the game of Go without human knowledge
David Silver et al.
NATURE (2017)
Harnessing off-target effects
Gaye Saginc et al.
NATURE CHEMICAL BIOLOGY (2017)
Polypharmacology-based ceritinib repurposing using integrated functional proteomics
Brent M. Kuenzi et al.
NATURE CHEMICAL BIOLOGY (2017)
TRAPP webserver: predicting protein binding site flexibility and detecting transient binding pockets
Antonia Stank et al.
NUCLEIC ACIDS RESEARCH (2017)
The target landscape of clinical kinase drugs
Susan Klaeger et al.
SCIENCE (2017)
Epidermal growth factor receptor exon 20 mutation in lung cancer: types, incidence, clinical features and impact on treatment
Vanita Noronha et al.
ONCOTARGETS AND THERAPY (2017)
Dual protein kinase and nucleoside kinase modulators for rationally designed polypharmacology
Kahina Hammam et al.
NATURE COMMUNICATIONS (2017)
The anthelmintic praziquantel is a human serotoninergic G-protein-coupled receptor ligand
John D. Chan et al.
NATURE COMMUNICATIONS (2017)
ExCAPE-DB: an integrated large scale dataset facilitating Big Data analysis in chemogenomics
Jiangming Sun et al.
JOURNAL OF CHEMINFORMATICS (2017)
Combination therapy in combating cancer
Reza Bayat Mokhtari et al.
ONCOTARGET (2017)
Detecting similar binding pockets to enable systems polypharmacology
Miguel Duran-Frigola et al.
PLOS COMPUTATIONAL BIOLOGY (2017)
Molecular Connectivity Predefines Polypharmacology: Aliphatic Rings, Chirality, and sp3 Centers Enhance Target Selectivity
Stefania Monteleone et al.
FRONTIERS IN PHARMACOLOGY (2017)
Structural and Functional View of Polypharmacology
Aurelio Moya-Garcia et al.
SCIENTIFIC REPORTS (2017)
Utilizing random Forest QSAR models with optimized parameters for target identification and its application to target-fishing server
Kyoungyeul Lee et al.
BMC BIOINFORMATICS (2017)
Germline and Somatic Smoothened Mutations in Non-Small-Cell Lung Cancer Are Potentially Responsive to Hedgehog Inhibitor Vismodegib
Anne S. Tsao et al.
JCO PRECISION ONCOLOGY (2017)
Inotuzumab Ozogamicin: First Global Approval
Yvette N. Lamb
DRUGS (2017)
Privileged Structures Revisited
Petra Schneider et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)
New drugs, new toxicities: severe side effects of modern targeted and immunotherapy of cancer and their management
Frank Kroschinsky et al.
CRITICAL CARE (2017)
Polypharmacology of Approved Anticancer Drugs
Ivano Amelio et al.
CURRENT DRUG TARGETS (2017)
Novel 1-Phenyl-3-hydroxy-4-pyridinone Derivatives as Multifunctional Agents for the Therapy of Alzheimer's Disease
Rong Sheng et al.
ACS CHEMICAL NEUROSCIENCE (2016)
IsoMIF Finder: online detection of binding site molecular interaction field similarities
Matthieu Chartier et al.
BIOINFORMATICS (2016)
STITCH 5: augmenting protein-chemical interaction networks with tissue and affinity data
Damian Szklarczyk et al.
NUCLEIC ACIDS RESEARCH (2016)
BindingDB in 2015: A public database for medicinal chemistry, computational chemistry and systems pharmacology
Michael K. Gilson et al.
NUCLEIC ACIDS RESEARCH (2016)
PubChem Substance and Compound databases
Sunghwan Kim et al.
NUCLEIC ACIDS RESEARCH (2016)
Predicting unintended effects of drugs based on off-target tissue effects
Docyong Kim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Spotting and designing promiscuous ligands for drug discovery
P. Schneider et al.
CHEMICAL COMMUNICATIONS (2016)
Polypharmacology in Drug Development: A Minireview of Current Technologies
Zhi Tan et al.
CHEMMEDCHEM (2016)
Getting the most out of PubChem for virtual screening
Sunghwan Kim
EXPERT OPINION ON DRUG DISCOVERY (2016)
AutoT&T v.2: An Efficient and Versatile Tool for Lead Structure Generation and Optimization
Yan Li et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2016)
Boosting Docking-Based Virtual Screening with Deep Learning
Janaina Cruz Pereira et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2016)
ChemProt-3.0: a global chemical biology diseases mapping
Jens Kringelum et al.
DATABASE-THE JOURNAL OF BIOLOGICAL DATABASES AND CURATION (2016)
Badapple: promiscuity patterns from noisy evidence
Jeremy J. Yang et al.
JOURNAL OF CHEMINFORMATICS (2016)
Epigenetic polypharmacology: from combination therapy to multitargeted drugs
Angel R. de Lera et al.
CLINICAL EPIGENETICS (2016)
Comprehensive Modeling and Discovery of Mebendazole as a Novel TRAF2-and NCK-interacting Kinase Inhibitor
Zhi Tan et al.
SCIENTIFIC REPORTS (2016)
Rational Polypharmacology: Systematically Identifying and Engaging Multiple Drug Targets To Promote Axon Growth
Hassan Al-Ali et al.
ACS CHEMICAL BIOLOGY (2015)
DOCK 6: Impact of New Features and Current Docking Performance
William J. Allen et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2015)
Bispecific antibodies and their applications
Gaowei Fan et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2015)
A global reference for human genetic variation
David M. Altshuler et al.
NATURE (2015)
Dark chemical matter as a promising starting point for drug lead discovery
Anne Mai Wassermann et al.
NATURE CHEMICAL BIOLOGY (2015)
BioGPS: Navigating biological space to predict polypharmacology, off-targeting, and selectivity
Lydia Siragusa et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2015)
Engineering CAR-T cells: Design concepts
Shivani Srivastava et al.
TRENDS IN IMMUNOLOGY (2015)
Systems biology approaches for advancing the discovery of effective drug combinations
Karen A. Ryall et al.
JOURNAL OF CHEMINFORMATICS (2015)
Comprehensive prediction of drug-protein interactions and side effects for the human proteome
Hongyi Zhou et al.
SCIENTIFIC REPORTS (2015)
PhIN: A Protein Pharmacology Interaction Network Database
Z. Wang et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2015)
Extended Graph-Based Models for Enhanced Similarity Search in Cavbase
Timo Krotzky et al.
IEEE-ACM TRANSACTIONS ON COMPUTATIONAL BIOLOGY AND BIOINFORMATICS (2014)
Curation and Analysis of Multitargeting Agents for Polypharmacological Modeling
A. Srinivas Reddy et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2014)
GES Polypharmacology Fingerprints: A Novel Approach for Drug Repositioning
Violeta I. Perez-Nueno et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2014)
Polypharmacology: Challenges and Opportunities in Drug Discovery
Andrew Anighoro et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
DrugBank 4.0: shedding new light on drug metabolism
Vivian Law et al.
NUCLEIC ACIDS RESEARCH (2014)
SwissTargetPrediction: a web server for target prediction of bioactive small molecules
David Gfeller et al.
NUCLEIC ACIDS RESEARCH (2014)
SuperPred: update on drug classification and target prediction
Janette Nickel et al.
NUCLEIC ACIDS RESEARCH (2014)
LINCS Canvas Browser: interactive web app to query, browse and interrogate LINCS L1000 gene expression signatures
Qiaonan Duan et al.
NUCLEIC ACIDS RESEARCH (2014)
Adverse Drug Reaction Prediction Using Scores Produced by Large-Scale Drug-Protein Target Docking on High-Performance Computing Machines
Montiago X. LaBute et al.
PLOS ONE (2014)
Repurposing drugs in oncology (ReDO)-cimetidine as an anti-cancer agent
Pan Pantziarka et al.
ECANCERMEDICALSCIENCE (2014)
VNP: Interactive Visual Network Pharmacology of Diseases, Targets, and Drugs
Q-N Hu et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2014)
TargetHunter: An In Silico Target Identification Tool for Predicting Therapeutic Potential of Small Organic Molecules Based on Chemogenomic Database
Lirong Wang et al.
AAPS JOURNAL (2013)
Ado-trastuzumab emtansine approved for advanced breast cancer
Kate Traynor
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY (2013)
Insights into polypharmacology from drug-domain associations
Aurelio A. Moya-Garcia et al.
BIOINFORMATICS (2013)
APoc: large-scale identification of similar protein pockets
Mu Gao et al.
BIOINFORMATICS (2013)
Structural Systems Pharmacology: A New Frontier in Discovering Novel Drug Targets
Hepan Tan et al.
CURRENT DRUG TARGETS (2013)
Tox21 to Date Steps toward Modernizing Human Hazard Characterization
Kellyn S. Betts
ENVIRONMENTAL HEALTH PERSPECTIVES (2013)
AutoGrow 3.0: An improved algorithm for chemically tractable, semi-automated protein inhibitor design
Jacob D. Durrant et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2013)
Comparing the Chemical Structure and Protein Content of ChEMBL, DrugBank, Human Metabolome Database and the Therapeutic Target Database
Christopher Southan et al.
MOLECULAR INFORMATICS (2013)
The Cancer Genome Atlas Pan-Cancer analysis project
John N. Weinstein et al.
NATURE GENETICS (2013)
VisANT 4.0: Integrative network platform to connect genes, drugs, diseases and therapies
Zhenjun Hu et al.
NUCLEIC ACIDS RESEARCH (2013)
Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
Daniel Martinez Molina et al.
SCIENCE (2013)
Soluble epoxide hydrolase inhibition and peroxisome proliferator activated receptor γ agonist improve vascular function and decrease renal injury in hypertensive obese rats
John D. Imig et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2012)
Growth of Ligand-Target Interaction Data in ChEMBL Is Associated with Increasing and Activity Measurement-Dependent Compound Promiscuity
Ye Hu et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2012)
Directory of Useful Decoys, Enhanced (DUD-E): Better Ligands and Decoys for Better Benchmarking
Michael M. Mysinger et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
NCATS launches drug repurposing program
Malorye Allison
NATURE BIOTECHNOLOGY (2012)
The Promise of Antibody-Drug Conjugates
Beverly A. Teicher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
ChEMBL: a large-scale bioactivity database for drug discovery
Anna Gaulton et al.
NUCLEIC ACIDS RESEARCH (2012)
idTarget: a web server for identifying protein targets of small chemical molecules with robust scoring functions and a divide-and-conquer docking approach
Jui-Chih Wang et al.
NUCLEIC ACIDS RESEARCH (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
A Critical Assessment of Combined Ligand- and Structure-Based Approaches to hERG Channel Blocker Modeling
Lei Du-Cuny et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2011)
FRED Pose Prediction and Virtual Screening Accuracy
Mark McGann
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2011)
Comprehensive analysis of kinase inhibitor selectivity
Mindy I. Davis et al.
NATURE BIOTECHNOLOGY (2011)
PROMISCUOUS: a database for network-based drug-repositioning
Joachim von Eichborn et al.
NUCLEIC ACIDS RESEARCH (2011)
DRAR-CPI: a server for identifying drug repositioning potential and adverse drug reactions via the chemical-protein interactome
Heng Luo et al.
NUCLEIC ACIDS RESEARCH (2011)
Bispecific Antibodies for Cancer Immunotherapy
Dafne Müller et al.
BIODRUGS (2010)
A new protein binding pocket similarity measure based on comparison of clouds of atoms in 3D: application to ligand prediction
Brice Hoffmann et al.
BMC BIOINFORMATICS (2010)
Molecular Scaffolds with High Propensity to Form Multi-Target Activity Cliffs
Ye Hu et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2010)
Polypharmacology Directed Compound Data Mining: Identification of Promiscuous Chemotypes with Different Activity Profiles and Comparison to Approved Drugs
Ye Hu et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2010)
PharmMapper server: a web server for potential drug target identification using pharmacophore mapping approach
Xiaofeng Liu et al.
NUCLEIC ACIDS RESEARCH (2010)
Target identification using drug affinity responsive target stability (DARTS)
Brett Lomenick et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
PocketMatch: A new algorithm to compare binding sites in protein structures
Kalidas Yeturu et al.
BMC BIOINFORMATICS (2008)
Role of hERG potassium channel assays in drug development
Birgit T. Priest et al.
CHANNELS (2008)
Fragment-based de Novo ligand design by multiobjective evolutionary optimization
Fabian Dey et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2008)
SuperTarget and Matador: resources for exploring drug-target relationships
Stefan Guenther et al.
NUCLEIC ACIDS RESEARCH (2008)
Lessons from ''lower'' organisms: What worms, flies, and zebrafish can teach us about human energy metabolism
Amnon Schlegel et al.
PLOS GENETICS (2007)
Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
Marcus Bantscheff et al.
NATURE BIOTECHNOLOGY (2007)
Recore: A fast and versatile method for scaffold hopping based on small molecule crystal structure conformations
Patrick Maass et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2007)
Relating protein pharmacology by ligand chemistry
Michael J. Keiser et al.
NATURE BIOTECHNOLOGY (2007)
TarFisDock: a web server for identifying drug targets with docking approach
Honglin Li et al.
NUCLEIC ACIDS RESEARCH (2006)
In silico search of putative adverse drug reaction related proteins as a potential tool for facilitating drug adverse effect prediction
Zhi Liang Ji et al.
TOXICOLOGY LETTERS (2006)
SiteEngines: recognition and comparison of binding sites and protein-protein interfaces
A Shulman-Peleg et al.
NUCLEIC ACIDS RESEARCH (2005)
Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy
RA Friesner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
The KEGG resource for deciphering the genome
M Kanehisa et al.
NUCLEIC ACIDS RESEARCH (2004)
A new bioinformatic approach to detect common 3D sites in protein structures
M Jambon et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2003)
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
R Edgar et al.
NUCLEIC ACIDS RESEARCH (2002)
Computer automated prediction of potential therapeutic and toxicity protein targets of bioactive compounds from Chinese medicinal plants
YZ Chen et al.
AMERICAN JOURNAL OF CHINESE MEDICINE (2002)
Protacs: Chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation
KM Sakamoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
分享论文
